Insmed, Inc. (INSM)
118.07
-2.68
(-2.22%)
USD |
NASDAQ |
Nov 12, 16:00
118.49
+0.42
(+0.36%)
After-Hours: 20:00
Insmed Market Cap : 25.90B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 25.90B |
| November 11, 2026 | 26.48B |
| November 10, 2026 | 26.21B |
| November 09, 2026 | 25.46B |
| November 06, 2026 | 25.09B |
| November 05, 2026 | 23.85B |
| November 04, 2026 | 24.13B |
| November 03, 2026 | 22.91B |
| November 02, 2026 | 23.97B |
| October 30, 2026 | 24.69B |
| October 29, 2026 | 24.47B |
| October 28, 2026 | 21.27B |
| October 27, 2026 | 20.83B |
| October 26, 2026 | 20.47B |
| October 23, 2026 | 20.39B |
| October 22, 2026 | 20.75B |
| October 21, 2026 | 20.53B |
| October 20, 2026 | 20.88B |
| October 19, 2026 | 20.80B |
| October 16, 2026 | 21.01B |
| October 15, 2026 | 21.66B |
| October 14, 2026 | 21.35B |
| October 13, 2026 | 21.13B |
| October 12, 2026 | 21.51B |
| October 09, 2026 | 21.96B |
| Date | Value |
|---|---|
| October 08, 2026 | 21.93B |
| October 07, 2026 | 22.21B |
| October 06, 2026 | 22.97B |
| October 05, 2026 | 22.66B |
| October 02, 2026 | 24.26B |
| October 01, 2026 | 23.70B |
| September 30, 2026 | 24.91B |
| September 29, 2026 | 25.24B |
| September 28, 2026 | 25.69B |
| September 25, 2026 | 25.72B |
| September 24, 2026 | 26.53B |
| September 23, 2026 | 25.83B |
| September 22, 2026 | 26.37B |
| September 21, 2026 | 26.41B |
| September 18, 2026 | 26.19B |
| September 17, 2026 | 27.06B |
| September 16, 2026 | 26.76B |
| September 15, 2026 | 26.18B |
| September 14, 2026 | 27.35B |
| September 11, 2026 | 28.25B |
| September 10, 2026 | 27.78B |
| September 09, 2026 | 28.11B |
| September 08, 2026 | 27.26B |
| September 04, 2026 | 27.57B |
| September 03, 2026 | 27.65B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Gilead Sciences, Inc. | 208.43B |
| Incyte Corp. | 24.83B |
| Vertex Pharmaceuticals, Inc. | 137.57B |
| Regeneron Pharmaceuticals, Inc. | 98.35B |
Market Cap Related Metrics
| PS Ratio | 16.81 |
| Price to Book Value | 35.66 |
| Price | 118.07 |
| Earnings Yield | -2.39% |